Contralaterally Controlled Functional Electrical Stimulation and Mirror Therapy for Upper Limb Function in Patients with Stroke

Effects of Contralaterally Controlled Functional Electrical Stimulation and Mirror Therapy for Motor Function of Upper Limb in Patients with Stroke: a pilot parallel randomized controlled trial

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000039958

Enrollment

Unknown

Registered

2020-11-15

Start date

2020-11-15

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

routine group:routine rehabilitation

Mirror therapy group:routine rehabilitation and mirror therapy

contralaterally controlled functional electrical stimulation group:routine rehabilitation and contralaterally controlled functional electrical stimulation

combined group:routine rehabilitation and combined contralaterally controlled functional electrical stimulation and mirror therapy

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with unilateral cerebral hemorrhage or cerebral infarction confirmed by CT or MRI and diagnosed the relevant criteria of Chinese Guidelines for Diagnosis and Treatment of Acute Ischemic Stroke 2018; 2. First stroke or previous lacunar cerebral infarction without sequelae; 3. Stroke duration is less than 6 months; 4. 18 years old = 24, primary school: MMES >= 20, illiteracy: MMES >= 17); Cooperate with treatment and evaluation; 8. Sign informed Consent.

Exclusion criteria

Exclusion criteria: 1. Previous history of stroke; 2. Contrainindications for Electrophysiological test and low-frequency electrical stimulation treatment: damaged epidermis, fever, history of tumor, wearing pacemaker, intracranial metal implants and other internal metal implants, skull defects, epilepsy patients, pregnancy, lactation, or women of childbearing age who have not taken reliable contraceptive measures 3. Severe systemic diseases could not participate in the study: patients with severe respiratory, heart, liver, kidney, endocrine and hematopoietic diseases, such as congestive heart failure, arrhythmia, and hypertension; 4. Significant limb disability or other diseases affecting upper limb movement: severe upper limb infection, contracture, joint surgery, amputation, fracture, rheumatism or rheumatoid arthritis; 5. Patients with severe cognitive, speech, visual, hearing impairment (such as deaf-mute) or mental disorders; 6. Patients who recently participated in other clinical trials.

Design outcomes

Primary

Measure	Time frame
Simplified Fugl-Meyer Assessment;	—

Secondary

Measure	Time frame
Action Research Arm Test;Brunnstrom stage;Modified Ashworth spasticity scale;Manual Muscle Test;Barthel index;sEMG;MEP;	—

Countries

China

Contacts

Public ContactBai Yulong

Huashan Hospital, Fudan University

dr_baiyl@fudan.edu.cn+86 13501974457

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026